Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 13
Submit an article Journal homepage
1,069
Views
1
CrossRef citations to date
0
Altmetric
Articles

Analysis of albumin as a prognostic factor in HHV-8/HIV-negative Castleman disease from a multicenter study

Tiantian Yua Department of Hematology and Oncology, The Second Affiliated Hospital of NanChang University, Nanchang, China
,
Qing-Qing Caib State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
,
Qiong-Li Zhaic Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
,
Ling Lid Department of Medical Oncology, Zhenzhou University Cancer Center, Zhenzhou, China
,
Xiaosheng Fange Department of Hematology and Oncology, Shandong Cancer Hospital, Shandong, China
,
Jianyong Lif Department of Hematology and Oncology, Jiangsu Province Hospital, Nanjing University, Nanjing, China
,
Ruifang Sung Department of Pathology, Shanxi Cancer Hospital, Shanxi, China
,
Hanjin Yangh Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
,
Zhaoming Wangh Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
,
Wenbian Qiani Department of Hematology and Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
,
Zijun Y. Xu-Monettej Division of Hematopathology and Department of Pathology, Duke University Medical Center, Durham, NC, USAORCID Iconhttps://orcid.org/0000-0002-7615-3949
ORCID Icon,
Ken H. Youngj Division of Hematopathology and Department of Pathology, Duke University Medical Center, Durham, NC, USA;k Duke University Cancer Center, Durham, NC, USAORCID Iconhttps://orcid.org/0000-0002-5755-8932
ORCID Icon &
Li Yua Department of Hematology and Oncology, The Second Affiliated Hospital of NanChang University, Nanchang, ChinaCorrespondence[email protected]
 show all
Pages 3082-3091 | Received 02 Mar 2022, Accepted 23 Aug 2022, Published online: 07 Sep 2022

References

  • Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer-Am Cancer Soc. 1956;9:822–830.
  • Weisenburger DD, Nathwani BN, Winberg CD, et al. Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Hum Pathol. 1985;16(2):162–172.
  • Liu AY, Nabel CS, Finkelman BS, et al. Idiopathic multicentric Castleman’s disease: a systematic literature review. Lancet Haematol. 2016;3(4):e163–e175.
  • Yu L, Tu M, Cortes J, et al. Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease. Blood. 2017;129(12):1658–1668.
  • Takai K, Nikkuni K, Shibuya H, et al. Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly. Rinsho Ketsueki 2010;51:320–5.
  • Iwaki N, Fajgenbaum DC, Nabel CS, et al. Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtype of HHV-8-negative multicentric Castleman disease. Am J Hematol. 2016;91(2):220–226.
  • Talat N, Schulte KM. Castleman’s disease: systematic analysis of 416 patients from the literature. Oncologist. 2011;16(9):1316–1324.
  • Fajgenbaum DC, Kurzrock R. Siltuximab: a targeted therapy for idiopathic multicentric Castleman disease. Immunotherapy-Uk. 2016;8(1):17–26.
  • Gerard L, Michot JM, Burcheri S, et al. Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease. Blood. 2012;119(10):2228–2233.
  • Lan X, Li Z, Zhang M. Analysis of clinical characteristics and prognosis factors of 71 cases with HIV-negative Castleman’s disease: hypoproteinemia is an unfavorable prognostic factor which should be treated appropriately. J Cancer Res Clin Oncol. 2018;144(7):1265–1277.
  • Zhang X, Rao H, Xu X, et al. Clinical characteristics and outcomes of Castleman disease: a multicenter study of 185 Chinese patients. Cancer Sci. 2018;109(1):199–206.
  • van Rhee F, Voorhees P, Dispenzieri A, et al. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease. Blood. 2018;132(20):2115–2124.
  • Merlot AM, Kalinowski DS, Richardson DR. Unraveling the mysteries of serum albumin-more than just a serum protein. Front Physiol. 2014;5:299.
  • Arroyo V, Garcia-Martinez R, Salvatella X. Human serum albumin, systemic inflammation, and cirrhosis. J Hepatol. 2014;61(2):396–407.
  • Fajgenbaum DC. Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease. Blood. 2018;132(22):2323–2330.
  • Casper C, Chaturvedi S, Munshi N, et al. Analysis of inflammatory and anemia-related biomarkers in a randomized, double-blind, placebo-controlled study of siltuximab (anti-IL6 monoclonal antibody) in patients with multicentric Castleman disease. Clin Cancer Res. 2015;21(19):4294–4304.
  • Fajgenbaum DC, Uldrick TS, Bagg A, et al. International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood. 2017;129(12):1646–1657.
  • Dispenzieri A, Fajgenbaum DC. Overview of Castleman disease. Blood. 2020;135(16):1353–1364.
  • Dong Y, Wang M, Nong L, et al. Clinical and laboratory characterization of 114 cases of Castleman disease patients from a single centre: paraneoplastic pemphigus is an unfavourable prognostic factor. Br J Haematol. 2015;169(6):834–842.
  • van Rhee F, Wong RS, Munshi N, et al. Siltuximab for multicentric Castleman’s disease: a randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2014;15(9):966–974.
  • Caraceni P, Tufoni M, Zaccherini G, et al. On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites. J Hepatol. 2021;74(2):340–349.
  • Yu L, Shi M, Cai Q, et al. A novel predictive model for idiopathic multicentric castleman disease: the international Castleman disease consortium study. Oncologist. 2020;25(11):963–973.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.